Effect of Nintedanib in Patients with Limited and Extensive Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Data from the SENSCIS Trial
N. Goh, C. Denton, D. Lynch, T. Maher, V. Smith, A. Prasse, V. Cottin, R. Spiera, C. Stock, M. Gahlemann, M. Alves, A. Wells
{"title":"Effect of Nintedanib in Patients with Limited and Extensive Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Data from the SENSCIS Trial","authors":"N. Goh, C. Denton, D. Lynch, T. Maher, V. Smith, A. Prasse, V. Cottin, R. Spiera, C. Stock, M. Gahlemann, M. Alves, A. Wells","doi":"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1525","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":120990,"journal":{"name":"A37. ILD THERAPY I","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"A37. ILD THERAPY I","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1525","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
